Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of Olopatadine Nasal Spray

NCT00578331 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00578331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00578331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of Olopatadine Nasal Spray
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
January 31, 2008
Enrollment
890 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perennial allergic rhinitis